EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.
about
Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy CombinationActivity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypesSelect Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma.Human Cytomegalovirus Promotes Survival of Infected Monocytes via a Distinct Temporal Regulation of Cellular Bcl-2 Family Proteins.Precision medicine in pediatric oncology
P2860
EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.
@en
type
label
EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.
@en
prefLabel
EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.
@en
P2093
P2860
P1476
EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.
@en
P2093
Dipan Karmali
Haneen A Abdella
Kelly C Goldsmith
Michael D Hogarty
Rachel Tanos
Srilatha Nalluri
Susan K Peirce
P2860
P304
P356
10.1080/15384047.2014.1002333
P577
2015-01-01T00:00:00Z